Felix Biotechnology
We’re creating programmable therapies
Biotech
Genomics
Therapeutics
About
We are building the first end-to-end digital viral design platform to protect the world against the coming threat of antimicrobial resistance.
Build your own investing agent
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlistDetails
Status
Inactive
Stage
Early
Team Size
6
Regions
United States of America, America / Canada, Remote, Partly Remote